It was found that miR-98 decreased HCC cell proliferation by targeting EZH2 and suppressing the Wnt/β-catenin signaling pathway, resulting in a G0/G1 cell cycle arrest [36]. This evidence concerns the gene EZH2 and hepatocellular carcinoma.